By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Great Emphasis is Put on Research.

Pfizer invests EUR 54 million in Austrian-based research

Pfizer building in Viennna © Pfizer

New medicines are being developed in cooperation with local medical universities, research institutions and hospitals. Clinical research carried out by Pfizer focuses on new treatments for cancer, chronic-inflammatory diseases, cardiovascular diseases, rare diseases, pain and new vaccines. In 2017 Pfizer also invested EUR 54 million in Austria.

One example of the company’s cooperation in the field of clinical research is its partnership with the academic institution ABCSG. The study group led by Prof. Michael Gnant (Medical University of Vienna) heads a registration trial with a substance developed by Pfizer to treat breast cancer. The study is completely financed by Pfizer and ABCSG is in charge of data, patient and project management in 21 countries across the globe. 5,600 patients are to take part in the study over a period of fifteen years. 18 hospitals and about 500 patients are involved just in Austria. „The fact that responsibility for a globally implemented Phase III study is in Austrian hands is a nice acknowledgement of the longstanding work done by ABCSG”, explains Prof. Gnant, President of ABCSG.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Business Location Austria Oportunități pentru companii românești

    27. Sept. 2021/16.00 - 18.00, Bucharest, Romania

  • Business Location Austria Oportunități pentru companii românești

    28. Sept. 2021/ 16.00 - 18.00 Uhr, Cluj Napoca, Romania

Austria Map

Find the perfect location for your company

Reliability and expertise in the country and in the company are the convincing factors in selecting a business location. We can be justifiably proud but can still become even more attractive. This is something Austria should increasingly work on in the future!

Pfizer

Logo
More testimonials

news from the business location Austria

Smurfit Kappa launches district heat project

Just under a year after the new energy systems went into operation, the next major sustainability project relating to the facility in Upper Austria is already in the starting blocks for the Irish group Smurfit Kappa Nettingsdorf.

Keepers Child Safety GmbH

Keepers Child Safety was founded in Israel in late 2016 to answer the growing need to protect children wherever they play in the digital world. The cyber-tech startup - with currently over 20 employees - has developed proprietary AI and ML technology to monitor, detect and protect kids from toxic conversations (bullying, harassment, racism,..) on their smartphones whilst maintaining and protecting their privacy.

More news All blog posts